Literature DB >> 19787707

The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma.

Arindam Chaudhury1, Philip H Howe.   

Abstract

Transforming growth factor-beta (TGFbeta) is a secreted cytokine, which intricately controls a plethora of physiological and pathological processes during development and carcinogenesis. TGFbeta exerts antiproliferative effects and functions as a tumor suppressor during early stages of tumorigenesis, whereas at later stages it functions as a tumor promoter aiding in metastatic progression through an autocrine TGFbeta loop. Intricate knowledge of TGFbeta signaling and its regulation are still evolving. In this review, we make an attempt to showcase the associated enigma of TGFbeta signaling in its dual functional role as tumor suppressor and metastatic promoter during early and late stages of carcinogenesis, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787707      PMCID: PMC2810629          DOI: 10.1002/iub.239

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  154 in total

1.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 2.  Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 3.  Complex networks orchestrate epithelial-mesenchymal transitions.

Authors:  Jean Paul Thiery; Jonathan P Sleeman
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

4.  A very private TGF-beta receptor embrace.

Authors:  Joan Massagué
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

Review 5.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

6.  Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.

Authors:  G Giannelli; C Bergamini; E Fransvea; C Sgarra; S Antonaci
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

7.  ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.

Authors:  Thomas Waerner; Memetcan Alacakaptan; Ido Tamir; Rupert Oberauer; Annamaria Gal; Thomas Brabletz; Martin Schreiber; Martin Jechlinger; Hartmut Beug
Journal:  Cancer Cell       Date:  2006-09       Impact factor: 31.743

8.  Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.

Authors:  Wenjun Ju; Atsushi Ogawa; Joerg Heyer; Dirk Nierhof; Liping Yu; Raju Kucherlapati; David A Shafritz; Erwin P Böttinger
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

9.  Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.

Authors:  Jay Groppe; Cynthia S Hinck; Payman Samavarchi-Tehrani; Chloe Zubieta; Jonathan P Schuermann; Alexander B Taylor; Patricia M Schwarz; Jeffrey L Wrana; Andrew P Hinck
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

10.  Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.

Authors:  Samy Lamouille; Rik Derynck
Journal:  J Cell Biol       Date:  2007-07-23       Impact factor: 10.539

View more
  34 in total

1.  Long form of latent TGF-β binding protein 1 (Ltbp1L) regulates cardiac valve development.

Authors:  Vesna Todorovic; Erin Finnegan; Laina Freyer; Lior Zilberberg; Mitsuhiko Ota; Daniel B Rifkin
Journal:  Dev Dyn       Date:  2011-01       Impact factor: 3.780

Review 2.  Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk.

Authors:  Amal Ahmed Abd El-Fattah; Nermin Abdel Hamid Sadik; Olfat Gamil Shaker; Amal Mohamed Kamal
Journal:  Mediators Inflamm       Date:  2018-10-25       Impact factor: 4.711

3.  Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.

Authors:  Yun Liang; Xi Qiu; Rong-zhen Xu; Xiao-ying Zhao
Journal:  J Zhejiang Univ Sci B       Date:  2011-07       Impact factor: 3.066

4.  Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy.

Authors:  Eoin P Brennan; Melissa J Morine; David W Walsh; Sarah A Roxburgh; Maja T Lindenmeyer; Derek P Brazil; Peadar Ó Gaora; Helen M Roche; Denise M Sadlier; Clemens D Cohen; Catherine Godson; Finian Martin
Journal:  Biochim Biophys Acta       Date:  2012-01-14

Review 5.  The Regulatory Effects of Transforming Growth Factor-β on Nerve Regeneration.

Authors:  Shiying Li; Xiaosong Gu; Sheng Yi
Journal:  Cell Transplant       Date:  2016-11-23       Impact factor: 4.064

6.  Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway.

Authors:  Sheng Yi; Fernando Pierucci-Alves; Bruce D Schultz
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-31       Impact factor: 4.249

7.  Effect of TAK1 on osteogenic differentiation of mesenchymal stem cells by regulating BMP-2 via Wnt/β-catenin and MAPK pathway.

Authors:  Hongpeng Yang; Yue Guo; Dawei Wang; Xiaofei Yang; Chengzhi Ha
Journal:  Organogenesis       Date:  2018-01-02       Impact factor: 2.500

Review 8.  Advances in mechanisms and signaling pathways of carbon nanotube toxicity.

Authors:  Jie Dong; Qiang Ma
Journal:  Nanotoxicology       Date:  2015-02-13       Impact factor: 5.913

9.  TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.

Authors:  Yoshiho Ikeuchi; Shorafidinkhuja Dadakhujaev; Amrita S Chandhoke; Mai Anh Huynh; Anna Oldenborg; Mikako Ikeuchi; Lili Deng; Eric J Bennett; J Wade Harper; Azad Bonni; Shirin Bonni
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

10.  SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma.

Authors:  Jian Wu; Min Zhang; Omar Faruq; Eldad Zacksenhaus; Wenming Chen; Aijun Liu; Hong Chang
Journal:  Biomark Res       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.